Application of orlistat in preparation of drugs for curing constipation
A technology for treating constipation with orlistat, applied in the field of medicine, can solve the problems of low solubility, undisclosed, high viscosity, etc., and achieve the effect of reducing oil spots and improving constipation symptoms
Active Publication Date: 2018-09-14
ZHONGSHAN WANHAN PHARM CO LTD
View PDF3 Cites 3 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Due to the high molecular weight, high viscosity and low solubility of natural KGM, its application is greatly limited. At present, natural KGM is mainly degraded by chemical or biological modification methods to obtain different molecular weights and different physical and chemical properties. Konjac glucomannan oligosaccharides (KOGM) with biological functions, and KOGM with different molecular weights have significant differences in physicochemical and biological functions
The combination of konjac glucomannan and orlistat as a drug for treating constipation has not yet been disclosed.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0029] Embodiment 1, orlistat and konjac glucomannan oligosaccharide tablet
[0030] Recipe 1:
[0031] Element
Dosage (g / tablet)
0.045g
Konjac Glucomannan Oligosaccharides
0.45g
1.365g
0.18g
0.36g
0.3g
0.3g
total
3.0g
[0032] Among them, the konjac glucomannan oligosaccharide consists of 12wt% KOGM-1, 65wt% KOGM-2 and 23wt% KOGM-3.
[0033] Formation 2:
[0034] Element
Dosage (g / tablet)
0.105g
Konjac Glucomannan Oligosaccharides
0.6g
1.2g
0.195g
Sodium starch glycolate
0.3g
0.3g
0.3g
total
3.0g
[0035] Among them, the konjac glucomannan oligosaccharide consists o...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention belongs to the medicine field and particularly relates to application of orlistat in preparation of drugs for curing constipation. The medicine comprises effective amount of orlistat andeffective amount of konjac glucomannan with different molecular weight, the medicine is formed by certain amount ratio of the konjac glucomannan and the orlistat, it is amazedly found that the medicine has remarkable effect for improving the constipation symptom, at the same time, oil stain and fatty excrement adverse reaction caused by orlistat taking can be effectively relieved, and compared with the prior art, remarkable improvement is obtained.
Description
technical field [0001] The invention belongs to the field of medicine, and in particular relates to the use of lisstat in the preparation of medicaments for treating constipation. Background technique [0002] Orlistat is usually used as a new type of weight loss drug, and it is the only non-central nervous weight loss drug. It is a long-acting and potent specific gastrointestinal lipase inhibitor. The active serine part of lipase and pancreatic lipase combines to form a covalent bond, which inactivates lipase and prevents the decomposition, absorption and utilization of fat in food, so as to achieve the purpose of weight loss. [0003] Although orlistat has a significant effect on weight loss, there are also many adverse reactions that cannot be ignored. Common adverse reactions include oily spots, urgency to defecate, oily spots, increased gastrointestinal exhaust, fatty stool, Increased bowel movements and bowel incontinence. Among them, the adverse reaction of increase...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/365A61K47/36A61P1/10
CPCA61K31/365A61K47/36A61P1/10
Inventor 杜志博向飞彭韪
Owner ZHONGSHAN WANHAN PHARM CO LTD




